- call +1-201-465-4211
- email sales@mrinsights.biz
The netupitant-palonosetron FDC is an oral therapy that targets two critical pathways associated with acute and delayed CINV by blockage of P/NK1 receptors. Netupitant in the central nervous system inhibits the binding of endogenous tachykinin neuropeptide substance, which prevents chemotherapy-induced nausea and vomiting (CINV).
Scope of the Report:
This report studies the Netupitant-Palonosetron FDC market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Netupitant-Palonosetron FDC market by product type and applications/end industries.
Presently, patient pool segment has witnessed large-scale adoption of netupitant-palonosetron FDC drugs due to rise in number of patient undergoing chemotherapy.
North America was the dominant regional market for netupitant‐palonosetron FDC drugs, in terms of revenue, due to growth in incidence of CINV among patients.
The global Netupitant-Palonosetron FDC market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Netupitant-Palonosetron FDC.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Eisai Pharmaceutical
Helsinn
Heron Therapeutics
Tesaro
Acacia Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Flakes
Capsules
Other
Market Segment by Applications, can be divided into
Hospital Pharmacy
Drug Stores
Retail Pharmacy
Online Pharmacy
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Netupitant-Palonosetron FDC Market Overview
1.1 Product Overview and Scope of Netupitant-Palonosetron FDC
1.2 Classification of Netupitant-Palonosetron FDC by Types
1.2.1 Global Netupitant-Palonosetron FDC Revenue Comparison by Types (2017-2023)
1.2.2 Global Netupitant-Palonosetron FDC Revenue Market Share by Types in 2017
1.2.3 Flakes
1.2.4 Capsules
1.2.5 Other
1.3 Global Netupitant-Palonosetron FDC Market by Application
1.3.1 Global Netupitant-Palonosetron FDC Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital Pharmacy
1.3.3 Drug Stores
1.3.4 Retail Pharmacy
1.3.5 Online Pharmacy
1.4 Global Netupitant-Palonosetron FDC Market by Regions
1.4.1 Global Netupitant-Palonosetron FDC Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Netupitant-Palonosetron FDC Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Netupitant-Palonosetron FDC Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Netupitant-Palonosetron FDC Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Netupitant-Palonosetron FDC Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Netupitant-Palonosetron FDC Status and Prospect (2013-2023)
1.5 Global Market Size of Netupitant-Palonosetron FDC (2013-2023)
2 Manufacturers Profiles
2.1 Eisai Pharmaceutical
2.1.1 Business Overview
2.1.2 Netupitant-Palonosetron FDC Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eisai Pharmaceutical Netupitant-Palonosetron FDC Revenue, Gross Margin and Market Share (2016-2017)
2.2 Helsinn
2.2.1 Business Overview
2.2.2 Netupitant-Palonosetron FDC Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Helsinn Netupitant-Palonosetron FDC Revenue, Gross Margin and Market Share (2016-2017)
2.3 Heron Therapeutics
2.3.1 Business Overview
2.3.2 Netupitant-Palonosetron FDC Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Heron Therapeutics Netupitant-Palonosetron FDC Revenue, Gross Margin and Market Share (2016-2017)
2.4 Tesaro
2.4.1 Business Overview
2.4.2 Netupitant-Palonosetron FDC Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Tesaro Netupitant-Palonosetron FDC Revenue, Gross Margin and Market Share (2016-2017)
2.5 Acacia Pharma
2.5.1 Business Overview
2.5.2 Netupitant-Palonosetron FDC Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Acacia Pharma Netupitant-Palonosetron FDC Revenue, Gross Margin and Market Share (2016-2017)
3 Global Netupitant-Palonosetron FDC Market Competition, by Players
3.1 Global Netupitant-Palonosetron FDC Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Netupitant-Palonosetron FDC Players Market Share
3.2.2 Top 10 Netupitant-Palonosetron FDC Players Market Share
3.3 Market Competition Trend
4 Global Netupitant-Palonosetron FDC Market Size by Regions
4.1 Global Netupitant-Palonosetron FDC Revenue and Market Share by Regions
4.2 North America Netupitant-Palonosetron FDC Revenue and Growth Rate (2013-2018)
4.3 Europe Netupitant-Palonosetron FDC Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Netupitant-Palonosetron FDC Revenue and Growth Rate (2013-2018)
4.5 South America Netupitant-Palonosetron FDC Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Netupitant-Palonosetron FDC Revenue and Growth Rate (2013-2018)
5 North America Netupitant-Palonosetron FDC Revenue by Countries
5.1 North America Netupitant-Palonosetron FDC Revenue by Countries (2013-2018)
5.2 USA Netupitant-Palonosetron FDC Revenue and Growth Rate (2013-2018)
5.3 Canada Netupitant-Palonosetron FDC Revenue and Growth Rate (2013-2018)
5.4 Mexico Netupitant-Palonosetron FDC Revenue and Growth Rate (2013-2018)
6 Europe Netupitant-Palonosetron FDC Revenue by Countries
6.1 Europe Netupitant-Palonosetron FDC Revenue by Countries (2013-2018)
6.2 Germany Netupitant-Palonosetron FDC Revenue and Growth Rate (2013-2018)
6.3 UK Netupitant-Palonosetron FDC Revenue and Growth Rate (2013-2018)
6.4 France Netupitant-Palonosetron FDC Revenue and Growth Rate (2013-2018)
6.5 Russia Netupitant-Palonosetron FDC Revenue and Growth Rate (2013-2018)
6.6 Italy Netupitant-Palonosetron FDC Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Netupitant-Palonosetron FDC Revenue by Countries
7.1 Asia-Pacific Netupitant-Palonosetron FDC Revenue by Countries (2013-2018)
7.2 China Netupitant-Palonosetron FDC Revenue and Growth Rate (2013-2018)
7.3 Japan Netupitant-Palonosetron FDC Revenue and Growth Rate (2013-2018)
7.4 Korea Netupitant-Palonosetron FDC Revenue and Growth Rate (2013-2018)
7.5 India Netupitant-Palonosetron FDC Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Netupitant-Palonosetron FDC Revenue and Growth Rate (2013-2018)
8 South America Netupitant-Palonosetron FDC Revenue by Countries
8.1 South America Netupitant-Palonosetron FDC Revenue by Countries (2013-2018)
8.2 Brazil Netupitant-Palonosetron FDC Revenue and Growth Rate (2013-2018)
8.3 Argentina Netupitant-Palonosetron FDC Revenue and Growth Rate (2013-2018)
8.4 Colombia Netupitant-Palonosetron FDC Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Netupitant-Palonosetron FDC by Countries
9.1 Middle East and Africa Netupitant-Palonosetron FDC Revenue by Countries (2013-2018)
9.2 Saudi Arabia Netupitant-Palonosetron FDC Revenue and Growth Rate (2013-2018)
9.3 UAE Netupitant-Palonosetron FDC Revenue and Growth Rate (2013-2018)
9.4 Egypt Netupitant-Palonosetron FDC Revenue and Growth Rate (2013-2018)
9.5 Nigeria Netupitant-Palonosetron FDC Revenue and Growth Rate (2013-2018)
9.6 South Africa Netupitant-Palonosetron FDC Revenue and Growth Rate (2013-2018)
10 Global Netupitant-Palonosetron FDC Market Segment by Type
10.1 Global Netupitant-Palonosetron FDC Revenue and Market Share by Type (2013-2018)
10.2 Global Netupitant-Palonosetron FDC Market Forecast by Type (2018-2023)
10.3 Flakes Revenue Growth Rate (2013-2023)
10.4 Capsules Revenue Growth Rate (2013-2023)
10.5 Other Revenue Growth Rate (2013-2023)
11 Global Netupitant-Palonosetron FDC Market Segment by Application
11.1 Global Netupitant-Palonosetron FDC Revenue Market Share by Application (2013-2018)
11.2 Netupitant-Palonosetron FDC Market Forecast by Application (2018-2023)
11.3 Hospital Pharmacy Revenue Growth (2013-2018)
11.4 Drug Stores Revenue Growth (2013-2018)
11.5 Retail Pharmacy Revenue Growth (2013-2018)
11.6 Online Pharmacy Revenue Growth (2013-2018)
12 Global Netupitant-Palonosetron FDC Market Size Forecast (2018-2023)
12.1 Global Netupitant-Palonosetron FDC Market Size Forecast (2018-2023)
12.2 Global Netupitant-Palonosetron FDC Market Forecast by Regions (2018-2023)
12.3 North America Netupitant-Palonosetron FDC Revenue Market Forecast (2018-2023)
12.4 Europe Netupitant-Palonosetron FDC Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Netupitant-Palonosetron FDC Revenue Market Forecast (2018-2023)
12.6 South America Netupitant-Palonosetron FDC Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Netupitant-Palonosetron FDC Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Netupitant-Palonosetron FDC Picture
Table Product Specifications of Netupitant-Palonosetron FDC
Table Global Netupitant-Palonosetron FDC and Revenue (Million USD) Ma
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
